Tokushima, Japan

Kazue Akiyama

This inventor holds 2 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazue Akiyama. Retrieved from https://idiyas.com/inventor/kazue-akiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazue Akiyama: Innovator in Medical Treatments

Introduction

Kazue Akiyama is a prominent inventor based in Tokushima, Japan. She has made significant contributions to the field of medicine, particularly in the development of treatments for various health conditions. With a total of 2 patents, her work has the potential to impact many lives.

Latest Patents

Kazue Akiyama's latest patents include an agent for preventing and treating disturbances of intestinal mucous and a method for treating diabetes mellitus. The diabetes treatment involves administering a pharmaceutically acceptable inert carrier combined with an effective amount of a carbostyril compound or its pharmaceutically acceptable salt. This innovative method targets specific molecular structures to enhance treatment efficacy.

Career Highlights

Kazue Akiyama is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues to advance her research and development efforts. Her work at Otsuka has allowed her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Katsuya Yamasaki and Kazushi Sakurai. Their collective expertise contributes to the innovative environment at Otsuka Pharmaceutical.

Conclusion

Kazue Akiyama's contributions to medical science through her patents and collaborations highlight her role as a key innovator in the industry. Her work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…